Catalyst Wire Dossier Catalyst Wire Dossier

Omacetaxine mepesuccinate

homoharringtonine
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Omacetaxine mepesuccinate, covering 2020-03-30 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients [Phase 2]

See pricing